| RS2117028700 |
AGK
|
Health Risk |
Pathogenic |
— |
| RS2117037405 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS2117037641 |
ASAH1
|
Health Risk |
Pathogenic |
— |
| RS2117040123 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2117047219 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS2117059286 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Papillary renal cell carcinoma type 1 |
| RS2117062104 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117062166 |
ASAH1
|
Health Risk |
Likely pathogenic |
— |
| RS2117062748 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS2117062966 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117063981 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS2117072529 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117072537 |
KCNH2
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2117072612 |
STAG3
|
Health Risk |
Pathogenic |
Premature ovarian failure 8, Premature ovarian failure 8 |
| RS2117072681 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS2117072816 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117078394 |
ASAH1
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2117107162 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Papillary renal cell carcinoma type 1 |
| RS2117107396 |
ASAH1
|
Health Risk |
Pathogenic |
— |
| RS2117113363 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2117113573 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2117124779 |
SHH
|
Health Risk |
Likely pathogenic |
— |
| RS2117124880 |
SHH
|
Health Risk |
Likely pathogenic |
— |
| RS2117124904 |
SHH
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS2117125420 |
SHH
|
Health Risk |
Likely pathogenic |
— |
| RS2117126444 |
RELN
|
Health Risk |
Likely pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117126655 |
SHH
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS2117128026 |
SHH
|
Health Risk |
Likely pathogenic |
— |
| RS2117128881 |
SHH
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS2117129739 |
ABCB1
|
Health Risk |
Likely pathogenic |
Idiopathic generalized epilepsy, Idiopathic generalized epilepsy |
| RS2117137466 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2117139699 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS2117151246 |
SHH
|
Health Risk |
Likely pathogenic |
— |
| RS2117166318 |
ATP6V0A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular acidosis, distal |
| RS2117166533 |
ATP6V0A4
|
Health Risk |
Pathogenic |
Distal renal tubular acidosis, Distal renal tubular acidosis |
| RS2117168257 |
RELN
|
Health Risk |
Likely pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117170464 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Norman-Roberts syndrome |
| RS2117188195 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117189408 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117204949 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117205170 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117206210 |
RP1L1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2117208388 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117226120 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 88, Retinal dystrophy |
| RS2117248586 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117254540 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS2117254954 |
RELN
|
Health Risk |
Pathogenic |
— |
| RS2117255104 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS2117255208 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117255599 |
NEFL
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 1F |
| RS2117256073 |
NEFL
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 1F, Charcot-Marie-Tooth disease type 1F |
| RS2117291505 |
ATP6V0A4
|
Health Risk |
Pathogenic |
Renal tubular acidosis, distal |
| RS2117315457 |
STAG3
|
Health Risk |
Likely pathogenic |
Non-obstructive azoospermia, Premature ovarian insufficiency |
| RS2117331664 |
STAG3
|
Health Risk |
Likely pathogenic |
Hypomyelination and Congenital Cataract, Hypomyelination and Congenital Cataract |
| RS2117333857 |
STAG3
|
Health Risk |
Pathogenic |
Spermatogenic failure 61, Spermatogenic failure 61 |
| RS2117348851 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS2117350995 |
RELN
|
Health Risk |
Likely pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2117399949 |
STAG3
|
Health Risk |
Likely pathogenic |
— |
| RS2117434759 |
AKR1D1
|
Health Risk |
Likely pathogenic |
— |
| RS2117509052 |
CPA1
|
Health Risk |
Likely pathogenic |
— |
| RS2117524953 |
STAG3
|
Health Risk |
Pathogenic |
PRIMARY OVARIAN FAILURE 8, PRIMARY OVARIAN FAILURE 8 |
| RS2117674119 |
CEP41
|
Health Risk |
Pathogenic |
Joubert syndrome 15, Joubert syndrome 15 |
| RS2117943840 |
TRPM6
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS2117944381 |
PTCH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS2117946757 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117947811 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117947928 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117949826 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117951765 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117953276 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117954271 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117955248 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2117955781 |
PTCH1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2117956624 |
PTCH1
|
Health Risk |
Pathogenic |
Basal cell nevus syndrome 1, Basal cell nevus syndrome 1 |
| RS2117957845 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117958655 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2117960287 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117963353 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117965922 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117966753 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117967310 |
NANS
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Genevieve type |
| RS2117970002 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117970934 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117973287 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117975028 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117976305 |
PTCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2117998071 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2118015234 |
TMC1
|
Health Risk |
Likely pathogenic |
— |
| RS2118020615 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118026370 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118027397 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118027698 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118030407 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2118031073 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118033907 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2118034227 |
PTCH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2118037130 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118041703 |
PTCH1
|
Health Risk |
Pathogenic |
Basal cell nevus syndrome 1, Basal cell nevus syndrome 1 |
| RS2118044176 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2118044447 |
PTCH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |